Sambria Pharmaceuticals
www.sambriapharma.comSambria Pharmaceuticals, LLC is a consumer healthcare products and pharmaceutical development firm that markets innovative, OTC pain relief and related topically administered medications that address the growing needs of clinicians and patients. Sambria Pharmaceutical's innovative trans-dermal delivery system provides for rapid onset of action and deep penetration of therapeutics that under typical conditions have limited cutaneous absorption, in particular topical anesthetics such as lidocaine, benzocaine, tetracaine and others in the amino benzoate and amino ester anesthetic class of drugs. Sambria's current focus is providing its rapid onset of action topical anesthetic to the dermatology, podiatry, pediatric, cosmetic/aesthetic medicine and other specialties where rapid onset of anesthetic serves the clinician and patient needs. If you are a clinician within these specialties and have an interest in learning about Sambria's rapid onset, trans-dermal permeation enhanced topical anesthetics, please feel free to contact us via email at [email protected] or call directly 888.246.6601. Sambria is currently seeking highly motivated, skilled independent representatives and distributors who have established relationships and a proven track record of success. To be considered for an independent rep position among the growing Sambria team, please contact us through email directly to [email protected]. There are still territories in regions throughout the United States.
Read moreSambria Pharmaceuticals, LLC is a consumer healthcare products and pharmaceutical development firm that markets innovative, OTC pain relief and related topically administered medications that address the growing needs of clinicians and patients. Sambria Pharmaceutical's innovative trans-dermal delivery system provides for rapid onset of action and deep penetration of therapeutics that under typical conditions have limited cutaneous absorption, in particular topical anesthetics such as lidocaine, benzocaine, tetracaine and others in the amino benzoate and amino ester anesthetic class of drugs. Sambria's current focus is providing its rapid onset of action topical anesthetic to the dermatology, podiatry, pediatric, cosmetic/aesthetic medicine and other specialties where rapid onset of anesthetic serves the clinician and patient needs. If you are a clinician within these specialties and have an interest in learning about Sambria's rapid onset, trans-dermal permeation enhanced topical anesthetics, please feel free to contact us via email at [email protected] or call directly 888.246.6601. Sambria is currently seeking highly motivated, skilled independent representatives and distributors who have established relationships and a proven track record of success. To be considered for an independent rep position among the growing Sambria team, please contact us through email directly to [email protected]. There are still territories in regions throughout the United States.
Read moreCountry
State
Georgia
City (Headquarters)
Atlanta
Industry
Employees
1-10
Founded
2012
Estimated Revenue
$1 to $1,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Operations Officer
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****
Technologies
(12)